Back to All Events

Fully Human Antibody Discovery Using Nanovials and Plasma Cells From ATX-GKTM Mice

Webinar

Pairing Alloy Therapeutics’ best-in-class transgenic humanized mouse with Partillion Biosciences’ Nanovial technology provides a simple and cost-efficient method to perform high throughput screens of antibody secreting plasma cells for the discovery of antigen-specific antibodies. In this webinar, we demonstrate an antibody discovery workflow that yields diverse, high affinity binders with development potential in therapeutic settings.

Learn how:

  • ATX-Gx™ industry-leading humanized mouse models can be harnessed as in vivo human antibody discovery platform for generating a robust and diverse immune response

  • Nanovial technology can screen hundreds of thousands of fragile antibody-secreting plasma without the need for expensive instrumentation or lengthy workflows.

  • Plasma cells are a rich source of high affinity antibodies that have therapeutic potential

Previous
Previous
December 5

Next-generation Nanovial Platforms for Function-first Discovery of Rare Antibodies and T-cell Receptors